TARDBP and amyotrophic lateral sclerosis: The obtained results highlight a significant difference in HCs compared to ALS-ND and ALS-LS for the peptides derived from TDP-43 and HERV-K envelope protein, while no difference was observed in the human response between ALS-ND and ALS-LS (Figure 2).